Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome (Q61733617)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 December 2012
edit
Language Label Description Also known as
English
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome
scientific article published on 21 December 2012

    Statements

    Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit